Seng Cheng

Seng Cheng

Company: Pfizer

Job title: SVP & CSO, Rare Disease Research Unit

Seminars:

Industry Leaders Panel: Delivering on the Promise of Gene Therapies 9:00 am

Gene therapies continue to redefine the treatment of rare diseases, but these conditions present many distinct development challenges. This panel discussion will bring together experts from leading organizations in this field to analyse how we can overcome these hurdles to realize the potential of gene therapies Navigating uncharted territory: sharing the decisions industry pioneers have…Read more

day: Day One

Building an Industry-Leading Therapy Portfolio in Rare Disease 8:30 am

Working strategy and future commitment to gene therapy of rare diseases in Pfizer Role of external partnerships and collaborations for a sustainable gene therapy pipeline Infrastructure and supporting elements to support timely and broad access to emerging gene medicinesRead more

day: Day One

© Copyright 2018 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.